Proteomics is the ‘large scale study of proteins’. Proteins represent the actual functional molecules that regulate the activity and function of cells, and the fundamental importance of proteome-level information in biomedical research is widely accepted.
In short, proteomics enables researchers to analyse the nature and abundance of different proteins within biological samples (e.g. protein complexes, subcellular compartments, whole cells or tissues).
Accordingly, proteomic approaches play a central role in a broad range of research fields; from basic biology to clinical studies such as those investigating disease biomarkers and novel therapeutic strategies.
Proteomics research relies heavily on expensive instrumentation operated by expert users. The National network of Advanced Proteomics Infrastructure (NAPI) is a national technological and scientific infrastructure platform for proteomics that serves the life science research community in Norway.
We provide users with access to cutting edge proteomics technology and support with all aspects of proteomics projects.
NAPI partners include researchers from existing proteomics core facilities in Oslo, Bergen, Trondheim, Tromsø and Ås, as well as research groups with a strong focus on proteomics technology development. NAPI therefore combines the proteomics expertise available across Norway, streamlining collaborations and the development of new advanced techniques.
You can read more about the the research activities and techniques carried out within NAPI on the Research and Techniques pages of this website.
You can also submit enquiries about new projects with NAPI on our contact page.
NAPI is funded by the Research Council of Norway (Forskningsrådet) under the INFRASTRUKTUR National Financing Inititative.
Users who publish MS data generated in collaboration with a NAPI core facility should acknowledge the core facility in the relevant manuscript. A template acknowledgements text is available here.